
Kintara Therapeutics, Inc. (KTRA) Stock on a Steep Rise, Here’s Why
Kintara Therapeutics, Inc. (KTRA), a clinical-stage drug development company, closed Monday’s regular trading session at $0.50 after rocketing by 35.41% during the day. In the
Kintara Therapeutics, Inc. (KTRA), a clinical-stage drug development company, closed Monday’s regular trading session at $0.50 after rocketing by 35.41% during the day. In the
New Oriental Education & Technology Group Inc. (EDU), a company providing private educational services in China, closed Thursday’s regular session at $11.90 after a mammoth
Tilray, Inc. (TLRY), a global cannabis-lifestyle goods company, has surged 13.44% in the current market. Consequently, TLRY is trading at $7.98 at the time of
Twitter Inc. (TWTR), a popular networking site, closed Friday’s regular session at $39.31 after gaining an increase of 1.60% during the day. In the premarket,
Vipshop Holdings Ltd. (VIPS), an online discount retailer for various brands, closed Wednesday’s regular trading session at $9.21 after declining 3.96% during the day. In
ThermoGenesis Holdings, Inc. (THMO), a company involved in the development of automated technologies for cell-based therapies, soared 19.48% in Monday’s regular trading session and closed
Kingsoft Cloud Holdings Ltd. (KC), a company providing cloud services to different businesses and organizations, gained an increase of 1.62% during Thursday’s regular trading session
Aurora Cannabis Inc. (ACB), a company involved in the cannabis business, has gained an increase of 6.25% in the premarket trading session. Consequently, ACB was
Futu Holdings Ltd. (FUTU), a company that operates an online wealth management platform, has slid 5.11% in the premarket trading session. Consequently, FUTU stock was
DouYu International Holdings Ltd. (DOYU), a company that provides entertainment live streaming services and interactive games through its platform, has slid 10.09% in the pre-market